Acera Surgical

“Acera Surgical is a bioscience company developing and commercializing a portfolio of fully engineered materials for regenerative medicine. Acera’s electrospun fibers are sub-cellular in size and free of animal and human components. They are structurally similar to native human tissue, resist enzymatic degradation, offer both flexibility and strength, and allow effective healing before completely resorbing.

Backed by over ten years of academic and clinical research, which led to multiple patents in regenerative medicine and the first electrospun fiber matrix indicated for soft tissue repair.

Supported by Level I clinical evidence, Acera continues to pioneer in regenerative medicine with Restrata, the first electrospun fiber matrix indicated for wound management, including surgical and traumatic wounds.”